Size constancy in visual impairment: a comparison with normally sighted individuals

Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)
Ahalya Subramanian, Christine Dickinson

Abstract

Size judgements are usually based on size constancy. However, as the number of visual cues decreases, such as by decreasing the field of view, size judgements gradually change from those based on size constancy to those based on the visual angle. The present study investigated whether visually impaired (VI) individuals, most of whom do not have measurable stereoacuity and have visual field defects, might therefore make judgements based on visual angle rather than size constancy. Size constancy was measured on 42 VI and 20 normally sighted subjects. Results indicated that size judgements are similar for both VI and normally sighted individuals at 0.50 m, 1 and 2 m. Statistically significant differences were found at 3 m. Despite this it would appear that VI individuals are able to make judgements based on size constancy rather than the visual angle.

References

Jan 1, 1978·Perception·H W LeibowitzR B Post
Aug 1, 1966·Journal of the Optical Society of America·H Leibowitz, D Moore
Nov 1, 1961·Psychological Bulletin·W EPSTEINA CASEY

❮ Previous
Next ❯

Citations

Mar 18, 2011·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Shahina PardhanAhayla Subramanian
Feb 23, 2010·Neuropsychologia·Elisabeth HuberleHans-Otto Karnath

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.